Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Hydroxychloroquine in Patients with Repeated Implantation Failure
IRCT2017060634209N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hydroxychloroquine in Recurrent Implantation Failure (RIF), sponsored by Shahid Beheshti University of Medical Sciences. Started Jul 2017; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT2017060634209N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017060634209N1.